Related Experiment Videos

Challenges in managing anticoagulant therapy in patients with heart valve prostheses

Roel Vink1, Pieter-Willem Kamphuisen, Renée B van den Brink

  • 1University of Amsterdam, Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands. r.vink@amc.uva.nl

Expert Review of Cardiovascular Therapy
|May 11, 2007
PubMed

Insights

Managing anticoagulant therapy for mechanical heart valves involves ongoing debates. This review synthesizes current research and guidelines to offer practical recommendations for clinical practice.

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Background:

  • Mechanical heart valves necessitate lifelong anticoagulant therapy.
  • Current guidelines for managing anticoagulation present several areas of debate.
  • Optimizing anticoagulant therapy is crucial for patient safety and efficacy.

Purpose of the Study:

  • To review current literature and guidelines on anticoagulant therapy in mechanical heart valve patients.
  • To address debated topics including vitamin K antagonist intensity, perioperative management, and anticoagulation during pregnancy.
  • To formulate evidence-based recommendations for clinical practice.

Main Methods:

  • Comprehensive literature search of studies and guidelines related to anticoagulant therapy in mechanical heart valve patients.
  • Analysis of data concerning vitamin K antagonist dosing, noncardiac surgery management, and pregnancy-related anticoagulation.
  • Synthesis of findings to develop practical recommendations.

Main Results:

  • Significant variability exists in recommendations for anticoagulant management.
  • Key areas of debate include target international normalized ratio (INR) ranges, bridging strategies during surgery, and safety of anticoagulants in pregnancy.
  • Evidence supports individualized approaches based on patient-specific factors.

Conclusions:

  • Consensus on optimal anticoagulant management strategies is lacking in several key areas.
  • Clinical practice should be guided by a synthesis of available evidence and established guidelines.
  • Further research is needed to resolve ongoing debates in anticoagulant therapy for mechanical heart valve patients.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...